说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 内脏脂肪含量
1)  visceral adiposity
内脏脂肪含量
1.
Methods Eighty rats with different visceral adiposity were obtained through high fat feeding and weight loss method and were divided into normal model group,hypso-fat model group and weight relief group.
目的了解大鼠内脏脂肪含量对ghrelin分泌的影响。
2)  Visceral adipose area (VA)
腹腔内脏器脂肪含量
3)  visceral adipose mass
内脏脂肪量
1.
Relationship between visceral adipose mass and lipid metabolic disorder in high-fat Insulin resistant rats;
胰岛素抵抗大鼠内脏脂肪量与脂代谢紊乱的相关性研究
4)  liver lipid contents
肝脏脂肪含量
5)  Visceral fat
内脏脂肪
1.
10 weeks later, body weight, visceral fat mass,fasting glucose,fasting insulin,TNF,αand FFAs were determined,and HOMA-IR was calculated by the method HOMA-IR=.
目的:观察正常大鼠在高脂饮食诱导下形成肥胖后,胰岛素敏感性与内脏脂肪及空腹血TNF鄄α、FFAs变化的关系。
2.
Fasting plasma glucose(FPG),HbA1c,fasting insulin and visceral fat were evaluated.
目的:观察罗格列酮治疗对2型糖尿病内脏脂肪含量变化。
3.
Visceral fat results in insulin resistance through secreting multiple active proinflammatory adipokin.
在代谢综合征发展过程中,胰岛素抵抗起主要作用,而胰岛素抵抗与内脏脂肪密切相关。
6)  IMF content
肌内脂肪含量
1.
Genetic polymorphism of H-FABP gene and correlation analysis with IMF content in porcine;
猪H-FABP基因遗传多态性及与肌内脂肪含量的相关分析
2.
By using 265 pigs from eight breeds including Duroc,Landrace,Large White,Neijiang,Rongchang,Hanjiang Black,Hanzhong White,Bamei and wild ones, the genetic variations of 5`-upstream region from and the second intron in porcine H-FABP gene were checked by PCR-RFLP molecular marker with HinfⅠ、HaeⅢ and MspⅠ,and effect of H-FABP gene on IMF content was then analyzed by least square analysis.
利用PCR RFLP(HinfⅠ、HaeⅢ和MspⅠ3种限制性内切酶)分子标记技术,检测了杜洛克猪、长白猪、大白猪、内江猪、荣昌猪、汉江黑猪、汉中白猪、八眉猪和野猪共计265头猪H FABP基因5′上游区和第二内含子区的遗传变异,并利用最小二乘模型分析了H FABP基因对猪肌内脂肪含量的遗传效应。
补充资料:脑病合并内脏脂肪变性综合征


脑病合并内脏脂肪变性综合征
En?cephalopathy with fatty degeneration of the viscera,Reye syndrome

本病又称“瑞氏综合征”。非炎症性急性脑肿胀,伴有以肝脏为主的内脏脂肪变性。主要发生在小儿时期,以4个月~5岁最多。病因和发病机制不明。诊断要点:①小儿病前一周内先有病毒感染,常见的为上感、水痘和胃肠炎;②较早出现反复呕吐及意识改变;③病情发展迅速,意识障碍或昏迷;④脑脊液正常;⑤肝功能检查有SGOT及SGPT明显增高、血氨增高,凝血酶原时间延长;⑥血清CPK增高;⑦无神经系统限局性体征;⑧神经系统表现和肝功能异常不能用其他疾病解释;⑨活检证实有肝脂肪变性;⑩肝大、过度换气、惊厥、低血糖、乳酸脱氢酶增高。治疗包括:积极支持疗法,抗惊厥、降颅压及肝功能衰竭的治疗等。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条